A polygenic-informed approach to a predictive EEG signature empowers stratified antidepressant treatment
Enregistré dans:
Auteurs principaux: | Hannah Meijs, Bochao Lin, Guido van Wingen, Evian Gordon, Damiaan Denys, Bieke De Wilde, Jan Van Hecke, Peter Niemegeers, Kristel van Eijk, Jurjen Luykx |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/0838a0e7f5b145c1b04cdd4e32dd312b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Exploring the role of Polygenetic risk scores for MDD treatment outcome in sex and different antidepressants groups
par: Bochao Lin, et autres
Publié: (2021) -
Brainmarker-I: a transdiagnostic EEG biomarker predicting remission to various depression and ADHD treatments
par: Helena Voetterl, et autres
Publié: (2021) -
Investigating EEG biomarker specificity to combined rTMS with psychotherapy: Psychotherapy, rTMS or sham? A blinded prediction study
par: Amourie Prentice, et autres
Publié: (2021) -
Heartbeat evoked potential in major depressive disorder: Differential treatment prediction for antidepressant medication and rTMS
par: Lauren Zwienenberg, et autres
Publié: (2021) -
Genetic risk for schizophrenia is associated with altered visually-induced gamma band activity: evidence from a population sample stratified polygenic risk
par: S. I. Dimitriadis, et autres
Publié: (2021)